EXACT Sciences (NASDAQ:EXAS) specializes in the detection and prevention of cancer. Through a blend of innovative technologies and a focus on diagnostic tests, the company aims to revolutionize cancer care. EXACT Sciences is renowned for its development of non-invasive screening tests, with a flagship product designed for colorectal cancer detection that has set new standards in early diagnosis. Their operations extend to collaborating on groundbreaking research and fostering advancements in the field of molecular diagnostics. The company's objectives are centered on enhancing patient outcomes, increasing access to early detection methods, and continuing to expand its portfolio of cancer detection tests, making significant strides in the battle against this disease.